The training of students, research fellows, and clinicians, organized by the Education and Training Core, will form an integral part of this Wellstone Center proposal on """"""""Biomarkers for Therapy of FSHD"""""""". The core's goal is to prepare young scientists for independent careers studying skeletal muscle biology and muscular dystrophy, with a strong focus on FSHD, and to provide them with research skills, through mentoring and assistance, to facilitate their transition to productive careers in muscular dystrophy research. The Core will provide trainees for all the projects involved in this proposal. It will be directed by Drs. Bloch (Core Director), Emerson (P.I., and Core Co-Director) and Kunkel (co-P.I.), who, with oversight by the Center Advisory Committee and NIH staff, will work with Center investigators to recruit, appoint, fund and mentor trainees. All fellows will participate in collaborative research projects with Center investigators, to implement the goals of the Center and to acquire multidisciplinary expertise and training in muscle and muscular dystrophy research. The Core's activities, designed to enhance training, will include a biennial meeting with a FSHD patient group, and a research conference on FSHD organized as a satellite to the annual meeting of the American Society for Human Genetics, and an annual research retreat. The retreat will focus on education and mentoring, through afternoon """"""""mini-courses"""""""" on skeletal muscle biology and muscular dystrophy, a """"""""brown bag lunch"""""""" session on the Responsible Conduct of Scientific Research, formal presentations, informal discussions, and one-on-one mentoring sessions. The Center will recruit and appoint one predoctoral and one postdoctoral trainee and support them for up to 2 years, with additional funding to be made available thereafter through their mentors'laboratories or other sources. Supplementary funding for additional fellows will be provided by faculty research grants, and funds from the Boston Biomedical Research Institute and other participating institutions, with the expectation that there will be12 fellows participating in our Education and Training Core at any given time.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54HD060848-05
Application #
8380048
Study Section
Special Emphasis Panel (ZAR1-KM-J)
Project Start
Project End
2013-03-01
Budget Start
2012-09-01
Budget End
2013-08-31
Support Year
5
Fiscal Year
2012
Total Cost
$164,333
Indirect Cost
$63,796
Name
Boston Biomedical Research Institute
Department
Type
DUNS #
058893371
City
Watertown
State
MA
Country
United States
Zip Code
02472
Leung, Doris G; Wang, Xin; Barker, Peter B et al. (2018) Multivoxel proton magnetic resonance spectroscopy in facioscapulohumeral muscular dystrophy. Muscle Nerve 57:958-963
Wallace, Lindsay M; Saad, Nizar Y; Pyne, Nettie K et al. (2018) Pre-clinical Safety and Off-Target Studies to Support Translation of AAV-Mediated RNAi Therapy for FSHD. Mol Ther Methods Clin Dev 8:121-130
Giesige, Carlee R; Wallace, Lindsay M; Heller, Kristin N et al. (2018) AAV-mediated follistatin gene therapy improves functional outcomes in the TIC-DUX4 mouse model of FSHD. JCI Insight 3:
Chagarlamudi, Hema; Corbett, Alastair; Stoll, Marion et al. (2017) Bone health in facioscapulohumeral muscular dystrophy: A cross-sectional study. Muscle Nerve 56:1108-1113
Eichinger, Katy; Heatwole, Chad; Heininger, Susanne et al. (2017) Validity of the 6 minute walk test in facioscapulohumeral muscular dystrophy. Muscle Nerve 55:333-337
Ansseau, Eugénie; Vanderplanck, Céline; Wauters, Armelle et al. (2017) Antisense Oligonucleotides Used to Target the DUX4 mRNA as Therapeutic Approaches in FaciosScapuloHumeral Muscular Dystrophy (FSHD). Genes (Basel) 8:
Shaw, Natalie D; Brand, Harrison; Kupchinsky, Zachary A et al. (2017) SMCHD1 mutations associated with a rare muscular dystrophy can also cause isolated arhinia and Bosma arhinia microphthalmia syndrome. Nat Genet 49:238-248
Widrick, Jeffrey J; Alexander, Matthew S; Sanchez, Benjamin et al. (2016) Muscle dysfunction in a zebrafish model of Duchenne muscular dystrophy. Physiol Genomics 48:850-860
Chen, Jennifer Cj; King, Oliver D; Zhang, Yuanfan et al. (2016) Morpholino-mediated Knockdown of DUX4 Toward Facioscapulohumeral Muscular Dystrophy Therapeutics. Mol Ther 24:1405-11
Ansseau, Eugénie; Eidahl, Jocelyn O; Lancelot, Céline et al. (2016) Homologous Transcription Factors DUX4 and DUX4c Associate with Cytoplasmic Proteins during Muscle Differentiation. PLoS One 11:e0146893

Showing the most recent 10 out of 34 publications